Year: 2020
Type: Article
Title: Current regulatory approaches for accessing potential COVID-19 therapies
Author: Halimi, Vesa
Author: Daci, Armond
Author: Stojanovska, Simona
Author: Panovska Stavridis, Irina
Author: Stevanovic, Milena
Author: Filipce, Venko
Author: Grozdanova, Aleksandra
Abstract: AbstractThis commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinical trials. Since no therapies have been formally approved and completely effective and safe to date, the best clinical choice is acquired only after consistent and fair communication and collaboration between licensed clinicians, researchers, regulatory authorities, manufacturers and patients.
Publisher: Informa UK Limited
Relation: Journal of Pharmaceutical Policy and Practice
Identifier: oai:repository.ukim.mk:20.500.12188/30014
Identifier: http://hdl.handle.net/20.500.12188/30014Identifier: 10.1186/s40545-020-00222-6
Identifier: https://link.springer.com/content/pdf/10.1186/s40545-020-00222-6.pdfIdentifier: https://link.springer.com/article/10.1186/s40545-020-00222-6/fulltext.htmlIdentifier: https://link.springer.com/content/pdf/10.1186/s40545-020-00222-6.pdfIdentifier: 13
Identifier: 1
